Joyce F. Liu, MD, MPH
Posted: Thursday, October 25, 2018
Domenica Lorusso, MD, PhD, of the Instituto Nazionale Dei Tumori, discusses the role of PARP inhibitors in ovarian cancer treatment.
JNCCN Spotlights
View More
Resources
For your Patients